Vaccine and Infectious Disease Division

VIDD News

Featured News

HVTN

Seattle Times highlights HVTN and Fred Hutch

The Seattle Times featured two news stories as part of a two-part series July 15th and 18th, highlighting the accomplishments and contributions of Fred Hutch, especially VIDD’s HIV Vaccine Trials Network (HVTN) to developing a vaccine for HIV.


HUTCH NEWS covers the AIDS2016 meeting

HIV vaccine clinical trials take center stage at world's largest global health conference
'The HIV vaccine field is open for business,' said Fred Hutch's Dr. Larry Corey at International AIDS Society's biennial meeting in Durban, South Africa

Renewed hope for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection

Global AIDS conference returns to Africa: What's changed
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next

 


Past News

Building protection at HIV infection site
July 18, 2016 in Science Spotlight